Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Association of Insurance Status and Marital Status with Outcomes of Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

Yi Miao, MD PhD, Wei Xu, MD PhD, Lei Fan, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 5459.

https://doi.org/10.1182/blood-2019-127756

Published: 2019

Journal Articles

Health Insurance Status Impacts Rates of Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia

Jeremy Chang, MD, Sherry Zhang, MD, Mojtaba Akhtari, MD

Blood (2019) 134 (Supplement_1): 2581.

https://doi.org/10.1182/blood-2019-123738

Published: 2019

Journal Articles

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Hussain I Rangoonwala, MBBS, Jonathan Gootee, MD, Peter T. Silberstein, MD

Blood (2019) 134 (Supplement_1): 3840.

https://doi.org/10.1182/blood-2019-131233

Published: 2019

Journal Articles

Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis

Nishi Shah, MBBS, MPH, Mohammad Kazemi, Stephen Zachary Peeke, MD, Lizamarie Bachier-rodriguez, R.Alejandro Sica, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Aditi Shastri, MD, Amit Verma, MBBS, Ioannis Mantzaris, MD MS

Blood (2019) 134 (Supplement_1): 426.

https://doi.org/10.1182/blood-2019-123168

Published: 2019

Journal Articles

Does Insurance Status Interfere with Outcomes in Patients with Hodgkin and Non-Hodgkin Lymphoma?: The UT Health San Antonio Experience

Juan F Garza, MD, Michelle Janania Martinez, MD, Prathibha Surapaneni, MD, Tyler W Snedden, MD, Snegha Ananth, MBBS, David J Gregorio, DO, Sushanth Kakarla, MD, Jeremy Rawlings, MD, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz, MD

Blood (2019) 134 (Supplement_1): 2141.

https://doi.org/10.1182/blood-2019-129085

Published: 2019

Journal Articles

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

Ivy Abraham, MD, Garth Rauscher, PhD MPH, Anand Ashwin Patel, MD, Wendy Stock, MD, Maryam Zia, MD, Sushma Bharadwaj, MD, Koosha Paydary, MD, Maria Acevedo-Mendez, John P Galvin, MDMS,MPH, William Pearse, MD, Jessica K. Altman, John G. Quigley, Priya Rajakumar, MD, Melissa L. Larson, MD, Irum Khan, MD

Blood (2019) 134 (Supplement_1): 3413.

https://doi.org/10.1182/blood-2019-124974

Published: 2019

Journal Articles

AML Clinical Trial Decision Making: How Often Do Physicians Follow a Consensus-Derived Assignment Scheme?

Kelda Gardner, PA-C, Mary-Elizabeth M. Percival, MD, Paul C. Hendrie, MD PhD, Anna B. Halpern, MD, Carole M. Shaw, BA, Jacob Appelbaum, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Roland B. Walter, MD PhD MS, Pamela S. Becker, MD PhD, Elihu H. Estey, MD

Blood (2019) 134 (Supplement_1): 5094.

https://doi.org/10.1182/blood-2019-131280

Published: 2019

Journal Articles

Impact of Insurance Status on Survival Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL): A Single Center Experience

Rebecca Krakora, BA, Weichung Shih, PhD, Pallvi Popli, MD, Elan Gorshein, DO, Gratian Salaru, MD, Kevin A. David, MD, Rajat Bannerji, MD PhD

Blood (2019) 134 (Supplement_1): 5071.

https://doi.org/10.1182/blood-2019-129390

Published: 2019

Journal Articles

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Lynn M. Malec, MD, Gilbert C. White, MD, Stacy E. Croteau, MD, Dunlei Cheng, PhD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 2467.

https://doi.org/10.1182/blood-2018-99-115231

Published: 2018

Journal Articles

Factors That Influence Treatment Decision-Making: Perspectives of 1147 Chronic Lymphocytic Leukemia (CLL) Patients in the United States

Blood (2018) 132 (Supplement 1): 4414.

https://doi.org/10.1182/blood-2018-99-112971

Published: 2018

Journal Articles

Access to Initial Treatment Was Not the Driving Force of the Survival Disparity By Insurance Status in Follicular Lymphoma — an Analysis of the National Cancer Database (NCDB)

Ning Dong, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Malik Faheem, MD, Shanthi Srinivas, MD, Victor T. Chang, MD

Blood (2018) 132 (Supplement 1): 4155.

https://doi.org/10.1182/blood-2018-99-120111

Published: 2018

Journal Articles

Worse Outcomes Associated with Public Insurance in AYAs with Leukemia and Lymphoma

Elysia Alvarez, MD MPH, Helen Parsons, Frances Maguire, Yi Chen, Cyllene Morris, Arti Parikh-Patel, Ted Wun, MD, Theresa H.M. Keegan, PhD MS

Blood (2018) 132 (Supplement 1): 977.

https://doi.org/10.1182/blood-2018-99-115519

Published: 2018

Journal Articles

Payment Plans Bridging Gap: An Equalizer for the Hispanic Population with Lymphoid Neoplasms in a Majority-Minority Community

Jessica Trevino Jones, MD, Sushanth Kakarla, MBBS, Annie Hung, MD, Michelle Janania Martinez, MD, Prathibha Surapaneni, Juan Garza, MD, David Gregorio, MD, Elva Nora Osuna Salazar, MD, Joel E Michalek, PhD, Qianqian Liu, MS, Adolfo E Diaz, MD

Blood (2018) 132 (Supplement 1): 2303.

https://doi.org/10.1182/blood-2018-99-115184

Published: 2018

Journal Articles

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

Kah Poh Loh, MBBCHBAO, Sindhuja Kadambi, MD, Supriya G. Mohile, MD MS, Jason H. Mendler, MD PhD, Jane L. Liesveld, MD, Kristen M. O'Dwyer, MD, Michael W. Becker, MD, Colin M. McHugh, MD, Marsha Wittink, MD MBE, Wendy Stock, MD, Navneet S. Majhail, MD MS, Tanya Wildes, MD, Paul Duberstein, PhD, Heidi D. Klepin, MD MS

Blood (2018) 132 (Supplement 1): 2246.

https://doi.org/10.1182/blood-2018-99-114178

Published: 2018

Journal Articles

A Look at Lymphoid Neoplasms in Patients over 65: Are We Less Aggressive - and Does It Affect Outcome?

Blood (2018) 132 (Supplement 1): 5910.

https://doi.org/10.1182/blood-2018-99-119584

Published: 2018

Journal Articles

Impact of Insurance Status on Survival of Patients Diagnosed with Acute Promyelocytic Leukemia in the United States

Omer Jamy, MD, Ana C. Xavier, MD, Luciano J Costa, MD PhD

Blood (2018) 132 (Supplement 1): 321.

https://doi.org/10.1182/blood-2018-99-116125

Published: 2018

Journal Articles

Disparities in survival by insurance status in follicular lymphoma

Jordan S. Goldstein, Loretta J. Nastoupil, Xuesong Han, Ahmedin Jemal, Elizabeth Ward, Christopher R. Flowers

Blood (2018) 132 (11): 1159–1166.

https://doi.org/10.1182/blood-2018-03-839035

Published: 2018

Includes: Supplemental data

Journal Articles

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Zahara Meghji, Raj Patel, MD, Prachi Jani, MD, Tanya S. Kakar, Mark A. Fiala, BS, Sonikpreet Aulakh, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 860.

https://doi.org/10.1182/blood.V130.Suppl_1.860.860

Published: 2017

Journal Articles

Survival Outcome and Insurance Status Among Hodgkin's Lymphoma (HL) Patients: Data from SEER 2007-2014

Qian Wang, MD MPH, Changchuan Jiang, MDMPH, Yaning Zhang, MD, Stuthi Perimbeti, MD MPH, Prateeth Pati, MD, Lawrence Cytryn, MD

Blood (2017) 130 (Supplement 1): 915.

https://doi.org/10.1182/blood.V130.Suppl_1.915.915

Published: 2017

Journal Articles

Insurance Status Impacts Survival in Burkitt Lymphoma

Jordan S. Goldstein, BS, Jeffrey M. Switchenko, PhD MS, Madhusmita Behera, PhD, Christopher Flowers, MD, Jean L. Koff, MD

Blood (2017) 130 (Supplement 1): 916.

https://doi.org/10.1182/blood.V130.Suppl_1.916.916

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Association of Insurance Status and Marital Status with Outcomes of Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

Health Insurance Status Impacts Rates of Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis

Does Insurance Status Interfere with Outcomes in Patients with Hodgkin and Non-Hodgkin Lymphoma?: The UT Health San Antonio Experience

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

AML Clinical Trial Decision Making: How Often Do Physicians Follow a Consensus-Derived Assignment Scheme?

Impact of Insurance Status on Survival Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL): A Single Center Experience

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Factors That Influence Treatment Decision-Making: Perspectives of 1147 Chronic Lymphocytic Leukemia (CLL) Patients in the United States

Access to Initial Treatment Was Not the Driving Force of the Survival Disparity By Insurance Status in Follicular Lymphoma — an Analysis of the National Cancer Database (NCDB)

Worse Outcomes Associated with Public Insurance in AYAs with Leukemia and Lymphoma

Payment Plans Bridging Gap: An Equalizer for the Hispanic Population with Lymphoid Neoplasms in a Majority-Minority Community

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

A Look at Lymphoid Neoplasms in Patients over 65: Are We Less Aggressive - and Does It Affect Outcome?

Impact of Insurance Status on Survival of Patients Diagnosed with Acute Promyelocytic Leukemia in the United States

Disparities in survival by insurance status in follicular lymphoma

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Survival Outcome and Insurance Status Among Hodgkin's Lymphoma (HL) Patients: Data from SEER 2007-2014

Insurance Status Impacts Survival in Burkitt Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only